Clinical Trial Update: Tailored Sonidegib Schedule After Complete Response in BCC [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring a tailored sonidegib schedule after complete response in locally advanced basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Sonidegib (Sonidegib)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Locally Advanced Basal Cell Carcinoma | Phase 2 | Status: UNKNOWN